Investigational Drug Information for Mitoquinone
✉ Email this page to a colleague
What is the development status for investigational drug Mitoquinone?
Mitoquinone is an investigational drug.
There have been 9 clinical trials for Mitoquinone.
The most recent clinical trial was a Phase 2 trial, which was initiated on May 1st 2006.
The most common disease conditions in clinical trials are Sclerosis, Multiple Sclerosis, and Fatigue. The leading clinical trial sponsors are Antipodean Pharmaceuticals, Inc., University of Colorado, Boulder, and MitoQ Ltd.
Summary for Mitoquinone
US Patents | 0 |
International Patents | 0 |
US Patent Applications | 38 |
WIPO Patent Applications | 9 |
Japanese Patent Applications | 4 |
Clinical Trial Progress | Phase 2 (2006-05-01) |
Vendors | 12 |
Recent Clinical Trials for Mitoquinone
Title | Sponsor | Phase |
---|---|---|
An Open Label Study in Healthy Adults to Test the Efficacy of Mitoquinone/Mitoquinol Mesylate as Prophylaxis for Development of Severe Viral Illness | University of California, Los Angeles | Phase 1/Phase 2 |
The Impact of Chronic Mitochondrial Antioxidant Supplementation on CardiovascularToxicity in Breast Cancer Patients | InCor Heart Institute | N/A |
The Impact of Chronic Mitochondrial Antioxidant Supplementation on CardiovascularToxicity in Breast Cancer Patients | Instituto do Cancer do Estado de São Paulo | N/A |
Clinical Trial Summary for Mitoquinone
Top disease conditions for Mitoquinone
Top clinical trial sponsors for Mitoquinone
US Patents for Mitoquinone
Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
---|---|---|---|---|
>Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |